References
- Bautista, C. T., Todd, C. S., Abed, A. M. S., Botros, B. A., Strathdee, S. A., Earhart, K. C., Safi, N., & Scott, P. T. (2010). Effects of duration of injection drug use and age at first injection on HCV among IDU in Kabul, Afghanistan. Journal of Public Health), 32(3), 336–341. https://doi.org/https://doi.org/10.1093/pubmed/fdq020
- Binka, M., Paintsil, E., Patel, A., Lindenbach, B. D., & Heimer, R. (2015). Survival of hepatitis C virus in syringes is dependent on the design of the syringe-needle and dead space volume. PLoS One, 10(11), e0139737. https://doi.org/https://doi.org/10.1371/journal.pone.0139737
- Broz, D., Zibbell, J., Foote, C., Roseberry, J. C., Patel, M. R., Conrad, C., Chapman, E., Peters, P. J., Needle, R., McAlister, C., & Duwve, J. M. (2018). Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana. The International Journal on Drug Policy, 52, 97–101. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.12.003
- Centers for Disease Control and Prevention. (2016). Hepatitis C kills more Americans than any other infectious disease.
- Centers for Disease Control and Prevention. (2019). Surveillance for viral hepatitis – United States, 2018. https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm
- Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR, 47, 1–39.
- Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011). Hepatitis C virus infection in USA: An estimate of true prevalence. Liver International : International, 31(8), 1090–1101. https://doi.org/https://doi.org/10.1111/j.1478-3231.2011.02494.x
- Cleland, C. M., Rosenblum, A., Fong, C., & Maxwell, C. (2011). Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs. Substance Abuse Treatment, Prevention, and Policy, 6, 11–11. https://doi.org/https://doi.org/10.1186/1747-597X-6-11
- Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet. Global Health, 5(12), e1192–e1207.https://doi.org/https://doi.org/10.1016/S2214-109X(17)30375-3
- Edlin, B. R., Eckhardt, B., Shu, M. A., Holmberg, S. D., & Swan, T. (2015). Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology, 62(5), 1353–1363. https://doi.org/https://doi.org/10.1002/hep.27978
- Firestone, M., & Fischer, B. (2008). A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: Behaviours, preferences and drug availability. Harm Reduction Journal, 5, 30–30. https://doi.org/https://doi.org/10.1186/1477-7517-5-30
- Fischer, B., Haydon, E., Rehm, J., Krajden, M., & Reimer, J. (2004). Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach-The case study of Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(3), 428–447. https://doi.org/https://doi.org/10.1093/jurban/jth128
- Gyarmathy, V. A., Neaigus, A., Li, N., Ujhelyi, E., Caplinskiene, I., Caplinskas, S., & Latkin, C. A. (2010). Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania. European Addiction Research, 16(4), 220–228. https://doi.org/https://doi.org/10.1159/000320287
- Hagan, H., Des Jarlais, D. C., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., & Flom, P. L. (2007). HCV synthesis project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal on Drug Policy, 18(5), 341–351. https://doi.org/https://doi.org/10.1016/j.drugpo.2007.01.016
- Havens, J. R., Lofwall, M. R., Frost, S. D. W., Oser, C. B., Leukefeld, C. G., & Crosby, R. A. (2013). Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. American Journal of Public Health, 103(1), e44–e52. https://doi.org/https://doi.org/10.2105/AJPH.2012.300874
- Havens, J. R., Walker, R., & Leukefeld, C. G. (2007). Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug and Alcohol Dependence, 87(1), 98–102. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2006.07.008
- Health and Human Services. (2013). Hepatitis C virus infection in young persons who inject drugs. https://www.aids.gov/pdf/hcv-and-young-pwid-consultation-report.pdf
- Iversen, J., Dertadian, G., Geddes, L., & Maher, L. (2017). High risk injecting behaviour among people who inject pharmaceutical opioids in Australia. The International Journal on Drug Policy, 42, 1–6. https://doi.org/https://doi.org/10.1016/j.drugpo.2016.12.004
- Johnson, K. M., Fibbi, M., Langer, D., Silva, K., & Lankenau, S. E. (2013). Prescription Drug Misuse and Risk Behaviors Among Young Injection Drug Users. Journal of Psychoactive Drugs, 45(2), 112–121. https://doi.org/https://doi.org/10.1080/02791072.2013.785811
- Judd, A., Hutchinson, S., Wadd, S., Hickman, M., Taylor, A., Jones, S., Parry, J. V., Cameron, S., Rhodes, T., Ahmed, S., Bird, S., Fox, R., Renton, A., Stimson, G. V., & Goldberg, D. (2005). Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: Cross sectional analysis. Journal of Viral Hepatitis, 12(6), 655–662. https://doi.org/https://doi.org/10.1111/j.1365-2893.2005.00643.x
- Lucidarme, D., Bruandet, A., Ilef, D., Harbonnier, J., Jacob, C., Decoster, A., Delamare, C., Cyran, C., Van Hoenacker, A. F., Fremaux, D., Josse, P., Emmanuelli, J., Le Strat, Y., Desenclos, J. C., & Filoche, B. (2004). Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiology and Infection, 132(4), 699–708. https://doi.org/https://doi.org/10.1017/S095026880400247X
- Magiorkinis, G., Sypsa, V., Magiorkinis, E., Paraskevis, D., Katsoulidou, A., Belshaw, R., Fraser, C., Pybus, O. G., & Hatzakis, A. (2013). Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Computational Biology, 9(1), e1002876. https://doi.org/https://doi.org/10.1371/journal.pcbi.1002876
- Mateu-Gelabert, P., Guarino, H., Jessell, L., & Teper, A. (2015). Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. Journal of Substance Abuse Treatment, 48(1), 13–20. https://doi.org/https://doi.org/10.1016/j.jsat.2014.07.002
- Oramasionwu, C. U., Bailey, S. C., Moore, H. N., Oramasionwu, C. O., Russell, A. L., & Zule, W. A. (2015). Dead space in over-the-counter syringes: The implications for HIV and HCV transmission. The International Journal on Drug Policy, 26(12), 1282–1284. https://doi.org/https://doi.org/10.1016/j.drugpo.2015.08.002
- Paintsil, E., He, H., Peters, C., Lindenbach, B. D., & Heimer, R. (2010). Survival of hepatitis C virus in syringes: Implication for transmission among injection drug users. The Journal of Infectious Diseases, 202(7), 984–990. https://doi.org/https://doi.org/10.1086/656212
- Paquette, C. E., & Pollini, R. A. (2018). Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug and Alcohol Dependence, 188, 239–250. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.03.049
- Pollini, R. A., Banta-Green, C. J., Cuevas-Mota, J., Metzner, M., Teshale, E., & Garfein, R. S. (2011). Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Substance Abuse and Rehabilitation, 2(1), 173–180. https://doi.org/https://doi.org/10.2147/SAR.S24800
- Quan, V. M., Go, V. F., Nam Le, V., Bergenstrom, A., Thuoc, N. P., Zenilman, J., Latkin, C., & Celentano, D. D. (2009). Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: A case-control study. AIDS Care, 21(1), 7–16. https://doi.org/https://doi.org/10.1080/09540120802017610
- Ramachandran, S., Thai, H., Forbi, J. C., Galang, R. R., Dimitrova, Z., Xia, G. L., Lin, Y., Punkova, L. T., Pontones, P. R., Gentry, J., Blosser, S. J., Lovchik, J., Switzer, W. M., Teshale, E., Peters, P., Ward, J., & Khudyakov, Y. (2018). A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015. EBioMedicine, 37, 374–381. https://doi.org/https://doi.org/10.1016/j.ebiom.2018.10.007
- Roy, E., Alary, M., Morissette, C., Leclerc, P., Boudreau, J. F., Parent, R., Rochefort, J., & Claessens, C. (2007). High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. International Journal of STD & AIDS, 18(1), 23–27. https://doi.org/https://doi.org/10.1258/095646207779949880
- Roy, É., Arruda, N., & Bourgois, P. (2011). The growing popularity of prescription opioid injection in downtown montréal: New challenges for harm reduction. Substance Use & Misuse, 46(9), 1142–1150. https://doi.org/https://doi.org/10.3109/10826084.2011.552932
- SAMHSA. (2017). Results from the 2016 national survey on drug use and health: detailed tables. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf
- Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths — United States, 2013–2017. Morbidity and Mortality Weekly Report, 67, 1419–1427.
- Stark, K., Müller, R., Bienzle, U., & Guggenmoos-Holzmann, I. (1996). Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. Aids, 10(3), 311–317. https://doi.org/https://doi.org/10.1097/00002030-199603000-00010
- Stanley, M., Guilfoyle, S., Vergeront, J., Davis, J., Suryaprasad, A., Hu, D., & Khudyakov, Y. (2012). Notes from the field: Hepatitis C virus infections among young adults–rural Wisconsin, 2010. Morbidity and Mortality Weekly Report, 61(19), 358.
- Surratt, H., Kurtz, S. P., & Cicero, T. J. (2011). Alternate routes of administration and risk for HIV among prescription opioid abusers. Journal of Addictive Diseases, 30(4), 334–341. https://doi.org/https://doi.org/10.1080/10550887.2011.609805
- Suryaprasad, A. G., White, J. Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., Hamdounia, S. B., Church, D. R., Barton, K., Fisher, C., Macomber, K., Stanley, M., Guilfoyle, S. M., Sweet, K., Liu, S., Iqbal, K., Tohme, R., Sharapov, U., Kupronis, B. A., Ward, J. W., & Holmberg, S. D. (2014). Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clinical Infectious Diseases : Diseases, 59(10), 1411–1419. https://doi.org/https://doi.org/10.1093/cid/ciu643
- Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., Monterroso, E. R., & Garfein, R. S. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155(7), 645–653. https://doi.org/https://doi.org/10.1093/aje/155.7.645
- Tracy, D., Hahn, J. A., Fuller Lewis, C., Evans, J., Briceno, A., Morris, M. D., Lum, P. J., & Page, K. (2014). Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: A prospective analysis from the UFO Study cohort. BMJ Open, 4(5), e004988. https://doi.org/https://doi.org/10.1136/bmjopen-2014-004988
- U.S. Department of Health and Human Services. (2018). About the U.S. opioid epidemic. Retrieved March 3, 2018, from https://www.hhs.gov/opioids/about-the-epidemic/
- Vickerman, P., Martin, N. K., & Hickman, M. (2013). Could low dead-space syringes really reduce HIV transmission to low levels? The International Journal on Drug Policy, 24(1), 8–14. https://doi.org/https://doi.org/10.1016/j.drugpo.2012.10.006
- Walsh, N., Verster, A., Rodolph, M., & Akl, E. A. (2014). WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs. International Journal on Drug Policy, 25(3), 363–371. https://doi.org/https://doi.org/10.1016/j.drugpo.2014.01.009
- Watts, T., Stockman, L., Martin, J., Guilfoyle, S., & Vergeront, J. M. (2017). Increased risk for mother-to-infant transmission of hepatitis C virus among medicaid recipients - Wisconsin, 2011-2015. Morbidity and Mortality Weekly Report, 66(42), 1136–1139. https://doi.org/https://doi.org/10.15585/mmwr.mm6642a3
- Wicker, S., Cinatl, J., Berger, A., Doerr, H. W., Gottschalk, R., & Rabenau, H. F. (2008). Determination of risk of infection with blood-borne pathogens following a needlestick injury in hospital workers. The Annals of Occupational Hygiene, 52(7), 615–622. https://doi.org/https://doi.org/10.1093/annhyg/men044
- World Health Organization. (2018). Hepatitis C fact sheet. Retrieved March 3, 2018, from http://www.who.int/mediacentre/factsheets/fs164/en/
- Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), e1–e7. https://doi.org/https://doi.org/10.2105/AJPH.2017.304132
- Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181. https://doi.org/https://doi.org/10.2105/AJPH.2017.304132
- Zibbell, J. E., Hart-Malloy, R., Barry, J., Fan, L., & Flanigan, C. (2014). Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. American Journal of Public Health, 104(11), 2226–2232. https://doi.org/https://doi.org/10.2105/AJPH.2014.302142
- Zibell, J. (2012). Safer injection 2.0: Beyond the Point1. Harm Reduction Communication, 17, 4–11.
- Zule, W. A., Cross, H. E., Stover, J., & Pretorius, C. (2013). Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. The International Journal on Drug Policy, 24(1), 1–7. https://doi.org/https://doi.org/10.1016/j.drugpo.2012.07.002
- Zule, W. A., & Desmond, D. P. (1997). Various types of injection equipment and risk of HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 16(4), 309. https://journals.lww.com/jaids/Fulltext/1997/12010/Various_Types_of_Injection_Equipment_and_Risk_of.15.aspx